Open access
Aug 2026
Frailty and Five-Year Mortality After TAVR in Patients Aged 75 Years and Older.
BACKGROUND Transcatheter aortic valve replacement (TAVR) is the standard treatment for older adults with symptomatic severe aortic stenosis. While cardiovascular predictors of long-term mortality after TAVR are well established, the impact of geriatric factors beyond short-term outcomes remains poorly defined. The main...
J. Huet, Mélissa Sabin, T. Letourneau et al.
· Journal of The American Geri... · 0 citations